Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Non-Current Debt (2024)

Universe Pharmaceuticals (UPC) has disclosed Non-Current Debt for 1 consecutive years, with $2.1 billion as the latest value for Q3 2024.

  • Quarterly Non-Current Debt changed N/A to $2.1 billion in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $2.1 billion through Sep 2024, changed N/A year-over-year, with the annual reading at $2.1 billion for FY2024, N/A changed from the prior year.
  • Non-Current Debt hit $2.1 billion in Q3 2024 for Universe Pharmaceuticals.
  • In the past five years, Non-Current Debt ranged from a high of $2.1 billion in Q3 2024 to a low of $2.1 billion in Q3 2024.